https://wikem.org/w/index.php?action=history&feed=atom&title=Template%3AAHA_SAH_BP_Guidelines%2FenTemplate:AHA SAH BP Guidelines/en - Revision history2026-04-18T06:07:26ZRevision history for this page on the wikiMediaWiki 1.38.2https://wikem.org/w/index.php?title=Template:AHA_SAH_BP_Guidelines/en&diff=382994&oldid=prevFuzzyBot: Updating to match new version of source page2026-01-18T02:17:47Z<p>Updating to match new version of source page</p>
<p><b>New page</b></p><div><noinclude><languages/></noinclude><br />
<br />
===AHA Aneurysmal SAH BP Guidelines<ref>Bederson J. et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025 [http://stroke.ahajournals.org/content/40/3/994.full.pdf PDF]</ref>===<br />
<br />
#No well-controlled studies exist that answer whether BP control influences rebleeding<br />
#BP should be controlled to balance the risk of stroke, hypertension-related rebleeding, and maintenance of cerebral perfusion pressure (Class I, [[Special:MyLanguage/EBQ:Evidence_Levels|Level of Evidence B]]).<br />
#Nicardipine, labetalol, and esmolol are appropriate choices for BP control (Sodium nitroprusside may raise intracranial pressure and cause toxicity with prolonged infusion and should be avoided)</div>FuzzyBot